US Stock MarketDetailed Quotes

TARA Protara Therapeutics

Watchlist

3.010
-0.030-0.99%

Close Nov 29 13:00 ET

2.950
-0.060-1.99%

Post 16:23 ET

62.10MMarket Cap-1140P/E (TTM)

Protara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

15.23%12.33M

-12.18%10.66M

21.77%11.85M

16.16%43.61M

10.50%11.04M

34.19%10.7M

39.46%12.14M

-10.50%9.73M

-20.94%37.55M

-2.87%9.99M

Selling and administrative expenses

-4.95%4.26M

-12.65%4.27M

-10.59%4.1M

-10.19%18.62M

-6.86%4.66M

-0.58%4.48M

-12.95%4.89M

-18.13%4.59M

-21.45%20.74M

-19.55%5M

-General and administrative expense

-4.95%4.26M

-12.65%4.27M

-10.59%4.1M

-10.19%18.62M

-6.86%4.66M

-0.58%4.48M

-12.95%4.89M

-18.13%4.59M

-21.45%20.74M

-19.55%5M

Research and development costs

29.78%8.07M

-11.87%6.39M

50.65%7.75M

48.67%24.99M

27.90%6.38M

79.40%6.22M

134.99%7.25M

-2.39%5.14M

-20.30%16.81M

22.64%4.99M

Operating profit

-15.23%-12.33M

12.18%-10.66M

-21.77%-11.85M

-16.16%-43.61M

-10.50%-11.04M

-34.19%-10.7M

-39.46%-12.14M

10.50%-9.73M

20.94%-37.55M

2.87%-9.99M

Net non-operating interest income expense

31.62%1.1M

35.04%1.14M

8.73%747K

191.03%3.18M

55.05%814K

196.11%838K

407.23%842K

477.31%687K

361.18%1.09M

789.83%525K

Non-operating interest income

31.62%1.1M

35.04%1.14M

8.73%747K

42.65%3.18M

28.80%814K

50.45%838K

64.45%842K

29.87%687K

12.97%2.23M

22.48%632K

Non-operating interest expense

----

-34.54%1.14M

-76.59%107K

Other net income (expense)

300.00%8K

175.00%11K

100.04%12K

-29.5M

Gain on sale of security

300.00%8K

175.00%11K

--9K

-29.41%12K

--6K

--2K

--4K

----

--17K

----

Special income (charges)

----

--0

----

---29.52M

----

-Less:Impairment of capital assets

----

--0

----

--29.52M

----

Income before tax

-13.78%-11.22M

15.77%-9.51M

-22.66%-11.1M

38.71%-40.42M

73.77%-10.22M

-28.20%-9.86M

-32.26%-11.29M

15.90%-9.05M

-39.58%-65.95M

-280.98%-38.97M

Income tax

Net income

-13.78%-11.22M

15.77%-9.51M

-22.66%-11.1M

38.71%-40.42M

73.77%-10.22M

-28.20%-9.86M

-32.26%-11.29M

15.90%-9.05M

-39.58%-65.95M

-280.98%-38.97M

Net income continuous Operations

-13.78%-11.22M

15.77%-9.51M

-22.66%-11.1M

38.71%-40.42M

73.77%-10.22M

-28.20%-9.86M

-32.26%-11.29M

15.90%-9.05M

-39.58%-65.95M

-280.98%-38.97M

Minority interest income

Net income attributable to the parent company

-13.78%-11.22M

15.77%-9.51M

-22.66%-11.1M

38.71%-40.42M

73.77%-10.22M

-28.20%-9.86M

-32.26%-11.29M

15.90%-9.05M

-39.58%-65.95M

-280.98%-38.97M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-13.78%-11.22M

15.77%-9.51M

-22.66%-11.1M

38.71%-40.42M

73.77%-10.22M

-28.20%-9.86M

-32.26%-11.29M

15.90%-9.05M

-39.58%-65.95M

-280.98%-38.97M

Basic earnings per share

42.53%-0.5

55.00%-0.45

-21.25%-0.97

39.08%-3.57

73.99%-0.9

-27.94%-0.87

-31.58%-1

16.67%-0.8

-39.19%-5.86

-280.22%-3.46

Diluted earnings per share

42.53%-0.5

55.00%-0.45

-21.25%-0.97

39.08%-3.57

73.99%-0.9

-27.94%-0.87

-31.58%-1

16.67%-0.8

-39.19%-5.86

-280.22%-3.46

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	15.23%12.33M	-12.18%10.66M	21.77%11.85M	16.16%43.61M	10.50%11.04M	34.19%10.7M	39.46%12.14M	-10.50%9.73M	-20.94%37.55M	-2.87%9.99M
Selling and administrative expenses	-4.95%4.26M	-12.65%4.27M	-10.59%4.1M	-10.19%18.62M	-6.86%4.66M	-0.58%4.48M	-12.95%4.89M	-18.13%4.59M	-21.45%20.74M	-19.55%5M
-General and administrative expense	-4.95%4.26M	-12.65%4.27M	-10.59%4.1M	-10.19%18.62M	-6.86%4.66M	-0.58%4.48M	-12.95%4.89M	-18.13%4.59M	-21.45%20.74M	-19.55%5M
Research and development costs	29.78%8.07M	-11.87%6.39M	50.65%7.75M	48.67%24.99M	27.90%6.38M	79.40%6.22M	134.99%7.25M	-2.39%5.14M	-20.30%16.81M	22.64%4.99M
Operating profit	-15.23%-12.33M	12.18%-10.66M	-21.77%-11.85M	-16.16%-43.61M	-10.50%-11.04M	-34.19%-10.7M	-39.46%-12.14M	10.50%-9.73M	20.94%-37.55M	2.87%-9.99M
Net non-operating interest income expense	31.62%1.1M	35.04%1.14M	8.73%747K	191.03%3.18M	55.05%814K	196.11%838K	407.23%842K	477.31%687K	361.18%1.09M	789.83%525K
Non-operating interest income	31.62%1.1M	35.04%1.14M	8.73%747K	42.65%3.18M	28.80%814K	50.45%838K	64.45%842K	29.87%687K	12.97%2.23M	22.48%632K
Non-operating interest expense	----	----	----	----	----	----	----	----	-34.54%1.14M	-76.59%107K
Other net income (expense)	300.00%8K	175.00%11K	9K	100.04%12K	6K	2K	4K		-29.5M
Gain on sale of security	300.00%8K	175.00%11K	--9K	-29.41%12K	--6K	--2K	--4K	----	--17K	----
Special income (charges)	----	----	----	--0	----	----	----	----	---29.52M	----
-Less:Impairment of capital assets	----	----	----	--0	----	----	----	----	--29.52M	----
Income before tax	-13.78%-11.22M	15.77%-9.51M	-22.66%-11.1M	38.71%-40.42M	73.77%-10.22M	-28.20%-9.86M	-32.26%-11.29M	15.90%-9.05M	-39.58%-65.95M	-280.98%-38.97M
Income tax
Net income	-13.78%-11.22M	15.77%-9.51M	-22.66%-11.1M	38.71%-40.42M	73.77%-10.22M	-28.20%-9.86M	-32.26%-11.29M	15.90%-9.05M	-39.58%-65.95M	-280.98%-38.97M
Net income continuous Operations	-13.78%-11.22M	15.77%-9.51M	-22.66%-11.1M	38.71%-40.42M	73.77%-10.22M	-28.20%-9.86M	-32.26%-11.29M	15.90%-9.05M	-39.58%-65.95M	-280.98%-38.97M
Minority interest income
Net income attributable to the parent company	-13.78%-11.22M	15.77%-9.51M	-22.66%-11.1M	38.71%-40.42M	73.77%-10.22M	-28.20%-9.86M	-32.26%-11.29M	15.90%-9.05M	-39.58%-65.95M	-280.98%-38.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-13.78%-11.22M	15.77%-9.51M	-22.66%-11.1M	38.71%-40.42M	73.77%-10.22M	-28.20%-9.86M	-32.26%-11.29M	15.90%-9.05M	-39.58%-65.95M	-280.98%-38.97M
Basic earnings per share	42.53%-0.5	55.00%-0.45	-21.25%-0.97	39.08%-3.57	73.99%-0.9	-27.94%-0.87	-31.58%-1	16.67%-0.8	-39.19%-5.86	-280.22%-3.46
Diluted earnings per share	42.53%-0.5	55.00%-0.45	-21.25%-0.97	39.08%-3.57	73.99%-0.9	-27.94%-0.87	-31.58%-1	16.67%-0.8	-39.19%-5.86	-280.22%-3.46
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data